Search for: "Par Pharmaceutical, Inc." Results 21 - 40 of 171
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Sep 2018, 9:16 pm by Patent Docs
Par Pharmaceutical, Inc. 1-18-cv-01224; filed August 10, 2018 in the District Court of Delaware • Plaintiff: Horizon Therapeutics, LLC • Defendants: Par Pharmaceuticals, Inc., Par Pharmaceutical Companies, Inc. [read post]
13 Jul 2018, 5:48 pm by Lawrence B. Ebert
Teva Pharmaceuticals USA, Inc., is apertinent intervening case, but did not explain how it isan intervening change in law to the inherency doctrine,especially given that it is an on-sale bar case. 855 F.3d1356 (Fed. [read post]
21 Mar 2018, 1:34 pm by Pierre T. Nguyen
Une de ces unicités a récemment refait surface dans la décision du Federal Circuit dans Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc.: la mise en vente pouvant faire anticiper un dépôt de brevet américain. [read post]
18 Jan 2018, 9:34 am by m zamora
WARNING LETTERMark BaumImprimis Pharmaceuticals Inc.12264 El Camino Real, Suite 350San Diego, CA 92130Dear Mr. [read post]
1 Nov 2017, 4:00 am by Administrator
TD Canada Trust, 2017 SCC 51 [1] A pharmaceutical company was the victim of a fraudulent cheque scheme implemented by one of its employees. [read post]
29 Sep 2017, 12:26 pm by Adam Weinstein
  IPOs and offerings of small pharmaceutical companies are incredibly risky – on par with the risks of penny stocks. [read post]
9 May 2017, 9:59 pm by Patent Docs
The decision arose out of a patent dispute between Plaintiffs Par Pharmaceutical, Inc., Par Sterile Products, LLC,... [read post]
8 Nov 2016, 11:53 pm by Kevin LaCroix
Actavis acquired Allergan, Inc. in June 2015 and the merged company took Allergan’s name. [read post]
21 Feb 2016, 8:07 pm by Patent Docs
Par Pharmaceutical, Inc. 1:15-cv-00886; filed October 2, 2015 in the District Court of Delaware Infringement of U.S. [read post]
26 Jan 2016, 11:23 am by Lawrence B. Ebert
**As one small footnote, Ampyra is not a disease-modifying treatment for MS, in contrast to Copaxone or to BNA report: [read post]
29 Nov 2015, 9:54 pm by Patent Docs
• Defendants: Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York LLC; Par Pharmaceutical, Inc. [read post]